Ranitidine (Zantac®) syrup versus ranitidine effervescent tablets (Zantac® EFFERdose®) in children: A single-center taste preference study

Pediatric Drugs

Volumn 8, Issue 4, 2006, Pages 265-270

  Ameen, Vanessa Z ^a   Pobiner, Bonnie F ^a   Giguere, Gregory C ^a   Carter, Eric G ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CAREGIVER; CHILD; CONTROLLED STUDY; DROWSINESS; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG LABELING; DRUG SAFETY; EFFERVESCENT TABLET; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYRUP; TASTE DISCRIMINATION; TASTE PREFERENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MENTHA PIPERITA; PATIENT SATISFACTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SOLUTION AND SOLUBILITY; TABLET; TASTE;

ADULT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MENTHA PIPERITA; PATIENT SATISFACTION; PHARMACEUTICAL SOLUTIONS; RANITIDINE; TABLETS; TASTE;

EID: 33747237651     PISSN: 11745878     EISSN: 11745878     Source Type: Journal    
DOI: 10.2165/00148581-200608040-00005     Document Type: Article

References (19)

1. Rudolph CD. Supraesophageal complications of gastroesophageal reflux in children: challenges in diagnosis and treatment. Am J Med 2003; 115 Suppl. 3A: 150S-6S
2. Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32 Suppl. 2: S1-31
3. Shepherd RW, Wren J, Evans S, et al. Gastroesophageal reflux in children: clinical profile, course and outcome with active therapy in 126 cases. Clin Pediatr 1987; 26: 55-60
4. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during infancy: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 1997; 151: 569-72
5. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 2000; 154: 150-4
6. El-Serag HB, Gilger M, Carter J, et al. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol 2004; 99: 806-12
7. Mallet E, Mouterde O, Dubois F, et al. Use of ranitidine in young infants with gastro-oesophageal reflux. Eur J Clin Pharmacol 1989; 36: 641-2
8. Goudsouzian NG, Young ET. The efficacy of ranitidine in children. Acta Anaesthesiol Scand 1987; 31: 387-90
9. Blumer JL, Rothstein FC, Kaplan BS, et al. Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease. J Pediatr 1985; 107: 301-6
10. Winnick S, Lucas DO, Hartman AL, et al. How do you improve compliance? Pediatrics 2005; 115: e718-24
11. Sanz EJ. Concordance and children's use of medicines. BMJ 2003; 327: 858-60
12. De Civita M, Dobkin PL. Pediatric adherence as a multidimensional and dynamic construct, involving a triadic partnership. J Pediatr Psychol 2004; 29: 157-69
13. Gibb DM, Goodall RL, Giacomet V, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003; 22: 56-62
14. Gold BD. Review article: epidemiology and management of gastro-oesophageal reflux in children. Aliment Pharmacol Ther 2004; 19 Suppl. 1: 22-7
15. Goresky GV, Finley GA, Bissonnette B, et al. Efficacy, duration, and absorption of a paediatric oral liquid preparation of ranitidine hydrochloride. Can J Anaesth 1992; 39: 791-8
16. Tolia V, Johnston G, Stolle J, et al. Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years. Pediatr Drugs 2004; 6: 127-31
17. Orenstein SR, Blumer JL, Faessel HM, et al. Ranitidine, 75mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 2002; 16: 899-907
18. Jack D, Thomas M, Skidmore IF. Ranitidine and paracetamol metabolism [letter]. Lancet 1985; II: 1067
19. Kim J, Keininger D, Becker S, et al. Simultaneous development of the Pediatric GERD Caregiver Impact Questionnaire (PGCIQ) in American English and American Spanish. Health Qual Life Outcomes 2005; 3: 5